Generated by AI
Summary of Sep 29's posts. Generated by AI.
No summary yet.
Summary of May 23's posts. Generated by AI.
Summary of Sep 28's posts. Generated by AI.
Investors talking about LFCR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
Lifecore Biomedical Inc. is a contract development and manufacturing organization focused on sterile injectable pharmaceuticals and medical device products. The company provides development, aseptic fill-finish, and commercial manufacturing services for products packaged in syringes, vials, and cartridges. It also produces pharmaceutical-grade hyaluronic acid, a biomaterial used in a range of medical applications, including ophthalmic and orthopedic products. Lifecore Biomedical Inc. serves pharmaceutical and medical device customers that need regulated manufacturing expertise, formulation support, and process scale-up capabilities. Headquartered in Chaska, Minnesota, the company operates in the biopharmaceutical manufacturing and biomaterials markets, where it plays a specialized role in supporting complex injectable therapies and related healthcare products.
Website3515 Lyman Boulevard
Chaska, MN, 55318
United States
The latest articles about LFCR.
Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data